Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative steroid for recovery after head and neck cancer surgery with free flap reconstruction
jRCTs031210593Phase 3Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in head and neck cancer (HNC) (2 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Quality of postoperative recovery. Started Feb 2022; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on jRCTs031210593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210593.